Regulations.gov document
Response Letter from FDA CDRH to Kambiz Tajkarimi
Other · FDA-2020-P-1864 · posted May 9, 2023
Key facts
| Document ID | FDA-2020-P-1864-0004 |
|---|---|
| Title | Response Letter from FDA CDRH to Kambiz Tajkarimi |
| Document type | Other |
| Subtype | Denial of Petition |
| Agency | FDA |
| Docket | FDA-2020-P-1864 |
| Posted | May 9, 2023 |
| Comment period opens | May 9, 2023 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: